Abstract
Executive summary
1. In adult cardiac surgery with cardiopulmonary bypass (CPB), avoiding hyperthermic perfusion (.37C) is recommended to reduce the risk of cardiac surgeryassociated acute kidney injury (CSA-AKI). (Class of Recommendation: I, Level of Evidence: B-R)
2. In adult cardiac surgery with CPB, a goal-directed oxygen delivery strategy is recommended to reduce the risk of CSA-AKI. (Class of Recommendation: I, Level
of Evidence: B-R)
3. In adult cardiac surgery with CPB, it is reasonable to adopt the Kidney Disease Improving Global Outcomes (KDIGO) practice guidelines for patients at high risk of AKI to reduce the risk of CSA-AKI. (Class of Recommendation IIA; Level of Evidence B-R)
4. In adult cardiac surgery with CPB, fenoldopam may be reasonable to reduce the risk of CSA-AKI, as long as hypotension is avoided. (Class of Recommendation: IIB, Level of Evidence: B-R)
5. In adult cardiac surgery with CPB, it might be reasonable to use minimally invasive extracorporeal circulation (MiECC) techniques to reduce the risk of CSA-AKI. (Class of Recommendation: IIB, Level of Evidence: B-R)
6. In adult cardiac surgery with CPB, dopamine infusion alone, during CPB and the perioperative period, is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: A)
7. In adult cardiac surgery with CPB, mannitol is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: B-R)
1. In adult cardiac surgery with cardiopulmonary bypass (CPB), avoiding hyperthermic perfusion (.37C) is recommended to reduce the risk of cardiac surgeryassociated acute kidney injury (CSA-AKI). (Class of Recommendation: I, Level of Evidence: B-R)
2. In adult cardiac surgery with CPB, a goal-directed oxygen delivery strategy is recommended to reduce the risk of CSA-AKI. (Class of Recommendation: I, Level
of Evidence: B-R)
3. In adult cardiac surgery with CPB, it is reasonable to adopt the Kidney Disease Improving Global Outcomes (KDIGO) practice guidelines for patients at high risk of AKI to reduce the risk of CSA-AKI. (Class of Recommendation IIA; Level of Evidence B-R)
4. In adult cardiac surgery with CPB, fenoldopam may be reasonable to reduce the risk of CSA-AKI, as long as hypotension is avoided. (Class of Recommendation: IIB, Level of Evidence: B-R)
5. In adult cardiac surgery with CPB, it might be reasonable to use minimally invasive extracorporeal circulation (MiECC) techniques to reduce the risk of CSA-AKI. (Class of Recommendation: IIB, Level of Evidence: B-R)
6. In adult cardiac surgery with CPB, dopamine infusion alone, during CPB and the perioperative period, is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: A)
7. In adult cardiac surgery with CPB, mannitol is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: B-R)
Original language | English |
---|---|
Pages (from-to) | 267-290 |
Number of pages | 24 |
Journal | Journal of ExtraCorporeal Technology |
Volume | 54 |
Issue number | 4 |
DOIs | |
Publication status | Published - Dec 2022 |
Keywords
- cardiac disease
- comorbidities
- kidney disease
- guidelines